Sangamo Therapeutics
SGMO
₹70.00
Share price
-4.35%
Change (1 day)
37.63%
Change (1 year)
Sangamo Therapeutics (SGMO) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : ₹6.73 Billion
According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are ₹6.73 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | ₹6.76 B | -1.41% |
| 2023-12-31 | ₹6.86 B | -69% |
| 2022-12-31 | ₹22.13 B | -14.17% |
| 2021-12-31 | ₹25.79 B | -20.05% |
| 2020-12-31 | ₹32.26 B | 120.95% |
| 2019-12-31 | ₹14.60 B | -6.41% |
| 2018-12-31 | ₹15.60 B | 147.22% |
| 2017-12-31 | ₹6.31 B | 328.06% |
| 2016-12-31 | ₹1.47 B | -10.53% |
| 2015-12-31 | ₹1.64 B | -28.92% |
| 2014-12-31 | ₹2.31 B | 96.18% |
| 2013-12-31 | ₹1.18 B | 22.37% |
| 2012-12-31 | ₹0.96 B | 153.4% |
| 2011-12-31 | ₹0.38 B | 19.92% |
| 2010-12-31 | ₹0.31 B | -56.26% |
| 2009-12-31 | ₹0.72 B | 21.36% |
| 2008-12-31 | ₹0.59 B | 29.5% |
| 2007-12-31 | ₹0.46 B | 47.51% |
| 2006-12-31 | ₹0.31 B | -37.65% |
| 2005-12-31 | ₹0.50 B | 394.27% |
| 2004-12-31 | ₹0.10 B | 42.16% |
| 2003-12-31 | ₹71.52 M | -24.71% |
| 2002-12-31 | ₹94.99 M | -26.21% |
| 2001-12-31 | ₹0.12 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | ₹3.393 T | 50,301.32% | 🇺🇸 USA |
 | ₹356.23 B | 5,191.18% | 🇺🇸 USA |
 | ₹7.338 T | 108,898.92% | 🇺🇸 USA |
 | ₹967.52 B | 14,270.51% | 🇺🇸 USA |
 | ₹3.368 T | 49,936.14% | 🇺🇸 USA |
 | ₹9.272 T | 137,621.42% | 🇺🇸 USA |
 | ₹113.62 B | 1,587.63% | 🇺🇸 USA |
 | ₹6.038 T | 89,589.98% | 🇺🇸 USA |